Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9875915 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL30686702 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL258034 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL29965332 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL258051 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL25260551 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL258197 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL258237 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL10946638 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL258154 | 1.00 | ALDH1A1 (0.76) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1896420-B1 | PROCESS OF PRODUCING BLEACH BOOSTERS | BASF SE (DE) | 2017-01-18 | — | — | EP | disclosed |
| US-20140288309-A1 | PROCESS OF PRODUCING BLEACH BOOSTERS | BASF SE (DE) | 2014-09-25 | — | — | US | disclosed |
| EP-1891195-B1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | PROCTER & GAMBLE (US) | 2012-10-17 | — | — | EP | disclosed |
| US-8147563-B2 | Organic catalyst with enhanced enzyme compatibility | THE PROCTER & GAMBLE COMPANY (US) | 2012-04-03 | — | — | US | disclosed |
| US-20110283463-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | THE PROCTER & GAMBLE COMPANY (US) | 2011-11-24 | — | — | US | disclosed |
| US-8021437-B2 | Organic catalyst with enhanced enzyme compatiblity | THE PROCTER & GAMBLE COMPANY (US) | 2011-09-20 | — | — | US | disclosed |
| US-20100223737-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBLITY | PROCTER & GAMBLE COMPANY, THE | 2010-09-09 | — | — | US | disclosed |
| US-20090222999-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBLITY | MIRACLE GREGORY SCOT | 2009-09-10 | — | — | US | disclosed |
| US-7557076-B2 | Organic catalyst with enhanced enzyme compatibility | THE PROCTER & GAMBLE COMPANY (US) | 2009-07-07 | — | — | US | disclosed |
| WO-2009060421-A2 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBLITY | THE PROCTER & GAMBLE COMPANY (US) | 2009-05-14 | — | — | WO | disclosed |
| US-20080200682-A1 | Process of Producing Bleach Boosters | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-21 | — | — | US | disclosed |
| EP-1896420-A1 | PROCESS OF PRODUCING BLEACH BOOSTERS | BASF SE (DE) | 2008-03-12 | — | — | EP | disclosed |
| EP-1891195-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | The Procter and Gamble Company (US) | 2008-02-27 | — | — | EP | disclosed |
| US-20070197417-A1 | Organic catalyst with enhanced enzyme compatiblity | PROCTER & GAMBLE COMPANY, THE | 2007-08-23 | — | — | US | disclosed |
| WO-2007001262-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-04 | — | — | WO | disclosed |
| WO-2006134143-A1 | PROCESS OF PRODUCING BLEACH BOOSTERS | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-21 | — | — | WO | disclosed |
| US-20060089284-A1 | Organic catalyst with enhanced enzyme compatibility | PROCTER & GAMBLE COMPANY, THE | 2006-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200682-A1 | Process of Producing Bleach Boosters | SQLE, BCHE, CAT | ALDH1A1 1143/4885TDP1 3016/4885SMN1; SMN2 2832/4885 |
| US-20140288309-A1 | PROCESS OF PRODUCING BLEACH BOOSTERS | SQLE, BCHE, CAT | ALDH1A1 1143/4885TDP1 3016/4885SMN1; SMN2 2832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.